We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$184B
AUM Growth
+$184B
Cap. Flow
+$1.06B
Cap. Flow %
0.58%
Top 10 Hldgs %
15.06%
Holding
4,187
New
96
Increased
2,386
Reduced
984
Closed
127

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$216M
2
CHTR icon
Charter Communications
CHTR
+$192M
3
SLB icon
SLB Ltd
SLB
+$79.3M
4
IBM icon
IBM
IBM
+$70.2M
5
NWL icon
Newell Brands
NWL
+$67.5M

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$72.2M
2
MSFT icon
Microsoft
MSFT
+$66.1M
3
UAA icon
Under Armour
UAA
+$63.2M
4
XOM icon
ExxonMobil
XOM
+$51.6M
5
WCN
Waste Connections
WCN
+$51.5M

Sector Composition

Rank Sector Weight
1 Healthcare 14.47%
2 Technology 14.08%
3 Financials 13.83%
4 Industrials 10.22%
5 Consumer Discretionary 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSRI
3076
DELISTED
Silver Standard Resources
SSRI
$596K ﹤0.01%
45,996
-48,900
-52% -$454K
CBIO
3077
Crescent Biopharma
CBIO
$626M
$595K ﹤0.01%
820
+305
+59% +$210K
TTNP
3078
DELISTED
Titan Pharmaceuticals
TTNP
$595K ﹤0.01%
30
+9
+43% +$192K
PZN
3079
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$594K ﹤0.01%
78,135
+3,225
+4% +$27.4K
AMBR
3080
DELISTED
Amber Road Inc
AMBR
$589K ﹤0.01%
76,405
+11,757
+18% +$68.6K
VYGR icon
3081
Voyager Therapeutics
VYGR
$198M
$587K ﹤0.01%
53,432
+960
+2% +$11.7K
RXII
3082
DELISTED
GALENA BIOPHARMA INC COM
RXII
$586K ﹤0.01%
1,258,625
+30,910
+3% +$14.4K
CAF
3083
Morgan Stanley China A Share Fund
CAF
$327M
0
AE
3084
DELISTED
Adams Resources & Energy Inc
AE
$584K ﹤0.01%
15,182
+53
+0.4% +$2.03K
EARN
3085
Ellington Residential Mortgage REIT
EARN
$165M
$581K ﹤0.01%
44,565
-7,264
-14% -$92K
KA
3086
DELISTED
Kineta, Inc. Common Stock
KA
$581K ﹤0.01%
343
+37
+12% +$67.4K
SPNS
3087
DELISTED
Sapiens International
SPNS
$579K ﹤0.01%
49,496
+3,861
+8% +$46.4K
PUK icon
3088
Prudential
PUK
$35.2B
$577K ﹤0.01%
17,504
-4,897
-22% -$180K
CYBE
3089
DELISTED
Cyberoptics Corp
CYBE
$577K ﹤0.01%
38,559
+16,858
+78% +$253K
NCOM
3090
DELISTED
National Commerce Corporation
NCOM
$576K ﹤0.01%
24,708
+2,960
+14% +$69.6K
RGLS
3091
DELISTED
Regulus Therapeutics
RGLS
$575K ﹤0.01%
1,659
+128
+8% +$91.7K
SEAC
3092
DELISTED
Seachange International Inc
SEAC
$575K ﹤0.01%
9,016
-1,550
-15% -$114K
IPAS
3093
DELISTED
Ipass Inc Common Stock
IPAS
$574K ﹤0.01%
46,367
TVRD
3094
Tvardi Therapeutics
TVRD
$23.4M
$573K ﹤0.01%
3,311
+87
+3% +$18.9K
CTSO icon
3095
Cytosorbents Corp
CTSO
$22.6M
$572K ﹤0.01%
125,772
UONEK icon
3096
Urban One Class D
UONEK
$23.8M
$572K ﹤0.01%
17,956
+3,241
+22% +$75.3K
CIGI icon
3097
Colliers International
CIGI
$5.19B
$571K ﹤0.01%
16,735
+1,670
+11% +$63.8K
ARGS
3098
DELISTED
Argos Therapeutics, Inc.
ARGS
$568K ﹤0.01%
4,636
+2,193
+90% +$293K
ASXC
3099
DELISTED
Asensus Surgical, Inc.
ASXC
$567K ﹤0.01%
35,790
+6,007
+20% +$189K
PMBC
3100
DELISTED
Pacific Mercantile Bancorp
PMBC
$567K ﹤0.01%
79,953
+17,605
+28% +$128K

Similar funds

Geode Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Geode Capital Management held 4,187 positions worth $184B, up 97,477% from $188M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Geode Capital Management's Q2 2016 filing shows 96 new, 2,386 increased, 984 reduced and 127 closed positions. Its largest new stake was S&P Global: 2,009,728 shares worth $215M. The largest sale was GE Aerospace, an estimated $72.2M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

  • Geode Capital Management's largest Q2 2016 buy was S&P Global: 2,009,728 shares worth $215M.
  • Geode Capital Management added most to Charter Communications in Q2 2016, an estimated $192M increase.
  • Geode Capital Management's biggest Q2 2016 reduction was GE Aerospace, cutting an estimated $72.2M.
  • Geode Capital Management fully exited Affymetrix Inc in Q2 2016, selling an estimated $7.53M.
  • Geode Capital Management's ten largest holdings make up 15% of its $184B portfolio in Q2 2016.
  • Geode Capital Management opened 96 new positions and closed 127 in Q2 2016.
  • Geode Capital Management's portfolio value rose 97,477% quarter-over-quarter to $184B.

Based on Geode Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.